Home / Locations / Bioluminux Naperville
Bioluminux Naperville, Illinois
About This Site
Our Naperville research site serves as our Global headquarters. It supports the greater Chicago area, as well as Phase 2–4 clinical trials across multiple therapeutic areas, including metabolic disorders, CNS, dermatology, vaccines, and many other therapeutic areas. The site is staffed by a dedicated team with deep experience in patient care and clinical operations.
With strong links to local healthcare providers and a diverse patient population, Naperville is well-positioned to meet enrolment targets quickly and deliver clean, reliable data. Sponsors benefit from our streamlined processes and commitment to quality at every stage of the trial.
Research Leadership
Orsolya Lawrence, BA (Hons) RICR, MBA(c)
Site Lead
Specialty:
Lisa Walinski, DO, Board Certified Family Medicine
Principal Investigator
Specialty:
Adeshola Ezeokoli, MD, Board Certified - Internal Medicine
Principal Investigator
Specialty:
Caroline Poku, MD, Board Certified - Internal Medicine - Endocrinology, Diabetes & Metabolism
Principal Investigator
Specialty:
Kimball Ladien, MD Boarded Certified Psychiatrist
Principal Investigator
Specialty:
Maria Malanych, MSN, APRN, FNP-BC
Sub-investigator
Specialty:
Site Facilities & Amenities
Recruiting Studies At This Location
Type 2 diabetes and high cholesterol
Recruitment for this study has ended but you can register your interest in future Type 2 diabetes trials. If you are interested in participating in similar studies in the future, please register your interest in similar studies in the future
COPD Antiviral Research Study
Do you have COPD? Bioluminux Clinical Research is conducting a research study evaluating an investigational antiviral medication that may help reduce the severity and duration of symptoms caused by common cold viruses in people living with COPD.